High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study

More effective therapeutic strategies are required for patients with poor-prognosis systemic sclerosis (SSc). A phase 2 single-arm study of high-dose immunosuppressive therapy (HDIT) and autologous CD34-selected hematopoietic cell transplantation (HCT) was conducted in 34 patients with diffuse cutan...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Nash, Richard A., McSweeney, Peter A., Crofford, Leslie J., Abidi, Muneer, Chen, Chien-Shing, Godwin, J. David, Gooley, Theodore A., Holmberg, Leona, Henstorf, Gretchen, LeMaistre, C. Fred, Mayes, Maureen D., McDonagh, Kevin T., McLaughlin, Bernadette, Molitor, Jerry A., Nelson, J. Lee, Shulman, Howard, Storb, Rainer, Viganego, Federico, Wener, Mark H., Seibold, James R., Sullivan, Keith M., Furst, Daniel E.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Hematology 2007
נושאים:
Transplantation
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC1939909/
https://ncbi.nlm.nih.gov/pubmed/17452515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-02-072389
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים